The Metabolomic Profile of Umbilical Cord Blood in Neonatal Hypoxic Ischaemic Encephalopathy
Open Access
- 5 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12), e50520
- https://doi.org/10.1371/journal.pone.0050520
Abstract
Hypoxic ischaemic encephalopathy (HIE) in newborns can cause significant long-term neurological disability. The insult is a complex injury characterised by energy failure and disruption of cellular homeostasis, leading to mitochondrial damage. The importance of individual metabolic pathways, and their interaction in the disease process is not fully understood. The aim of this study was to describe and quantify the metabolomic profile of umbilical cord blood samples in a carefully defined population of full-term infants with HIE. The injury severity was defined using both the modified Sarnat score and continuous multichannel electroencephalogram. Using these classification systems, our population was divided into those with confirmed HIE (n = 31), asphyxiated infants without encephalopathy (n = 40) and matched controls (n = 71). All had umbilical cord blood drawn and biobanked at −80°C within 3 hours of delivery. A combined direct injection and LC-MS/MS assay (AbsolutIDQ p180 kit, Biocrates Life Sciences AG, Innsbruck, Austria) was used for the metabolomic analyses of the samples. Targeted metabolomic analysis showed a significant alteration between study groups in 29 metabolites from 3 distinct classes (Amino Acids, Acylcarnitines, and Glycerophospholipids). 9 of these metabolites were only significantly altered between neonates with Hypoxic ischaemic encephalopathy and matched controls, while 14 were significantly altered in both study groups. Multivariate Discriminant Analysis models developed showed clear multifactorial metabolite associations with both asphyxia and HIE. A logistic regression model using 5 metabolites clearly delineates severity of asphyxia and classifies HIE infants with AUC = 0.92. These data describe wide-spread disruption to not only energy pathways, but also nitrogen and lipid metabolism in both asphyxia and HIE. This study shows that a multi-platform targeted approach to metabolomic analyses using accurately phenotyped and meticulously biobanked samples provides insight into the pathogenesis of perinatal asphyxia. It highlights the potential for metabolomic technology to develop a diagnostic test for HIE.This publication has 61 references indexed in Scilit:
- Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate modelJournal of Chromatography A, 2011
- Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopyChemical Society Reviews, 2011
- Outcome-Related Metabolomic Patterns from1H/31P NMR after Mild Hypothermia Treatments of Oxygen—Glucose Deprivation in a Neonatal Brain Slice Model of AsphyxiaJournal of Cerebral Blood Flow & Metabolism, 2010
- Metabolomic Analyses of Plasma Reveals New Insights into Asphyxia and Resuscitation in PigsPLOS ONE, 2010
- Hypoxic-Ischemic Encephalopathy in the Term InfantClinics in Perinatology, 2009
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxiaBrain & Development, 2009
- Carnitine Treatment Inhibits Increases in Cerebral Carnitine Esters and Glutamate Detected by Mass Spectrometry After Hypoxia-Ischemia in Newborn RatsStroke, 2006
- Performance of some variable selection methods when multicollinearity is presentChemometrics and Intelligent Laboratory Systems, 2005
- Value of biochemical markers for outcome in term infants with asphyxiaPediatric Neurology, 2004
- COMPARISON OF TWO METHODS OF PREDICTING OUTCOME IN PERINATAL ASPHYXIAThe Lancet, 1986